Abstract
When a colloidal droplet dries on a substrate, a unique pattern results from multi-facet phenomena such as Marangoni convection, capillary flow, mass transport, mechanical stress, colloid-colloid, and colloid-substrate interactions. Even under uniform conditions (surface wettability, humidity, and temperature), slight differences in the initial colloidal composition alter the drying pattern. This paper shows how the evolving patterns during drying in the sessile droplets depend on the initial composition and are crucial for assessing any abnormalities in the blood. To do so, texture statistics are derived from time-lapse images acquired during drying, and different traditional machine learning are applied. In addition, a neural network analysis is performed on both images and their texture statistics. As the drying phenomena are correlated with the varying composition, these methods exhibit excellent performance in distinguishing blood abnormalities with an Fl score of over 97%. This indicates that analysis of time-lapse images during drying and their texture statistics, rather than conventional analysis using images at the final dry state, are crucial for classification. Our results highlight the potential of droplet drying as a low-volume, accurate, and simple screening tool for detecting the type and stage of any disease in bio-fluid samples, such as blood, urine, and saliva.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research receives funding from UTOPIA (supported by AMED under Grant Number JP223fa627001) and the Japan Society for Promotion of Science (JSPS), KAKENHI Grant No. 23KF0104.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethics committee/IRB of The University of Tokyo waived the ethical approval for this work as the samples were purchased from a reputable company that adheres to all applicable rules and regulations regarding the collection and handling of biological specimens.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* apal{at}g.ecc.u-tokyo.ac.jp
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
